McKesson (MCK) demonstrated strong market performance, closing up 1.61% while the S&P 500 declined, and has gained 9.48% over the past month, significantly outperforming its sector. Analysts project robust growth for its upcoming earnings, with EPS expected to rise 25.74% to $8.89 and revenue by 10.94% to $103.9 billion for the quarter, alongside positive full-year forecasts and a 2.45% increase in recent consensus EPS estimates. Despite a Zacks Rank #3 (Hold), MCK trades at a premium with a Forward P/E of 20.23 compared to its industry's 13.05 average, though its PEG ratio of 1.39 is slightly below the industry average.
McKesson (MCK) demonstrated significant market outperformance, closing up 1.61% at $781.90 in a session where the S&P 500 declined by 0.16%. Over the past month, MCK shares surged 9.48%, substantially exceeding the Medical sector's 1.54% gain and the S&P 500's 1.14% increase. This robust price action suggests strong investor confidence. The company's upcoming earnings report on November 5, 2025, is anticipated to show strong growth, with projected EPS of $8.89, a 25.74% year-over-year increase, and revenue of $103.9 billion, up 10.94%. Full-year Zacks Consensus Estimates forecast EPS growth of 15.13% to $38.05 and revenue growth of 13.75%. Analyst sentiment is optimistic, evidenced by a 2.45% upward revision in the Zacks Consensus EPS estimate over the last month. Despite a Zacks Rank of #3 (Hold), McKesson trades at a premium valuation with a Forward P/E of 20.23, significantly above its industry average of 13.05. However, its PEG ratio of 1.39 is slightly below the industry average of 1.47, suggesting growth prospects may justify some of this premium. The Medical - Dental Supplies industry, with a Zacks Industry Rank of 80, is positioned in the top 33% of all industries.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment
